Follow CAP on Social Media

Listen to the CAP Podcast

With a Second Chinese Vaccine Getting the Nod From the WHO, Pressure Mounts on the U.S. to Get Its Own Vaccine Distribution Drive Going

The World Health Organization granted emergency use approval to Sinovac’s COVID-19 vaccine, the second Chinese jab to get the global health body’s seal of approval. In a statement on Tuesday, the WHO said Sinovac “meets international standards for safety, efficacy, and manufacturing,” providing badly-needed legitimacy to the Chinese-made vaccine.

WHO Director-General Tedros Adhanom Ghebreyesus welcomed the decision and noted the fact that the Sinovac vaccine doesn’t require costly subzero cold storage facilities, which makes it ideally suited for use in developing countries.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Africa Project?


The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.